Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Autologous infrapatellar fat pad stromal vascular fraction (IPFP-SVF) is a cell-based therapy derived from the adipose tissue located behind and below the patella (the infrapatellar fat pad). The stromal vascular fraction (SVF) is a heterogeneous mixture of cells obtained through the enzymatic digestion or mechanical processing of adipose tissue, containing adipose-derived stem cells (ADSCs), endothelial cells, pericytes, and various immune cells. In the context of orthopedic treatment, IPFP-SVF is typically administered via intra-articular injection to promote cartilage repair and reduce inflammation in patients with knee osteoarthritis or articular cartilage injuries. The therapeutic effect is believed to be mediated through the paracrine secretion of growth factors and cytokines that modulate the joint environment and support tissue regeneration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on autologous infrapatellar fat pad stromal vascular fraction.